A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial designJingran Ji, Mina S. Sedrak, Lisa D. Yee et al.|Therapeutic Advances in Medical Oncology|2026Cited by 1